Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-92,750
Closed -$10.3M 98
2022
Q4
$10.3M Buy
92,750
+22,300
+32% +$2.28M 2.3% 16
2022
Q3
$6.07M Buy
70,450
+65,589
+1,349% +$5.86M 1.44% 22
2022
Q2
$443K Buy
4,861
+4,111
+548% +$364K 0.13% 45
2022
Q1
$61.5K Buy
+750
New +$59.1K 0.01% 104
2020
Q1
Sell
-138,860
Closed -$12.1M 78
2019
Q4
$12.1M Buy
138,860
+58,478
+73% +$4.8M 2.44% 15
2019
Q3
$6.46M Buy
+80,382
New +$6.44M 1.45% 25
2019
Q1
Sell
-160,239
Closed -$11.7M 104
2018
Q4
$11.7M Buy
+160,239
New +$11.3M 2.62% 10

Other funds holding MRK

De Burlo Group's MRK Position: Q1 2023 in Review

De Burlo Group sold out of Merck (MRK) in Q1 2023, closing a stake of 92,750 shares — an estimated $10.3M sold.

De Burlo Group first reported a position in MRK in Q4 2018 and held it in 7 quarters. The position peaked at $12.1M in Q4 2019. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • De Burlo Group reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • De Burlo Group sold 92,750 Merck shares in Q1 2023, an estimated $10.3M.
  • De Burlo Group first reported a position in Merck in Q4 2018 and held it in 7 quarters.
  • De Burlo Group's Merck position peaked at $12.1M in Q4 2019.
  • 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on De Burlo Group's 13F filing for Q1 2023, filed 15 May 2023.